Oil for Life to Balance omega-3 polyunsaturated fatty acids ... - Oil4Life

consumption and questionnaire data in African American and Caucasian United
States males with and without prostatic carcinoma. Cancer Epidemiol. Biomarkers
Prev. 5: 115–119.
� Gokhan M., Atukeren P., Alturfan A.A., Gulyasar X.X., Kaya M., Gumustas
M.K. (2003) Lipid peroxidation, erythrocyte superoxide-dismutase activity and trace
metals in young male footballers. Yonsei Med. J. 44: 979– 86.
� Goldman L.S., Genel M., Bezman R.J., Slanetz P.J.(1998) Diagnosis and
treatment of attention-deficit/hyperactivity-disorder in children and adolescents.
JAMA 279: 1100-1107.
� Grønn M., Gørbitz C., Christensen E., Levorsen A., Ose, L., Hagve T.A.,
Christophersen B.O. (1991). Dietary n-6 fatty acids inhibit the incorporation of
dietary n-3 fatty acids in thrombocyte and serum phospholipids in humans: a
controlled dietetic study. Scand. J. Clin. Lab. Invest. 51: 255–263.
� Grundy, S.M. (1975) Effects of polyunsaturated fats on lipid metabolism in patients
with hypertriglyceridemia. J. Clin. Invest. 55:269.
� Guardiola F., Codony R., Addis P. B., Rafecas M., Boatella J. (1996) Biological
effects of oxysterols: current status. Food Chem.Toxicol. 34, 193-211.
� Guesens P., Wouters C., Nijs J., Jiang Y., De Queker J. (1994) Long-term effect
of n-3 fatty acid supplementation in active rheumatoid arthritis. A 12 month double
blind controlled study. Arth. Rhum. 37: 824-829.
� Haag M. (2003) Essential fatty acids and the brain. Can. J. Psychiat. 48: 195– 203.
� Halperin J.M., Newcorn J.H., Schwartz S.T., et al. (1993) Plasma catecholamine
metabolite levels in ADHD boys with and without reading disabilities. J. Clin. Child.
Psycol. 22: 219-225.
� Hamilton L., Greiner R., Salem N. Jr., et al. (2000) N-3 fatty acid deficency
decrease phosphatylserine accumulation selectively in neuronal tissues. Lipids 35:
863-869.
� Harel Z., Biro F.M., Kottenhahn R.K., Rosenthal S. (1996) Supplementation with
omega-3 polyunsaturated fatty acids in the management of dysmenorrhea in
adolescents. Am. J. Obstet. Gynecol. 174: 1335-1338.
� Harris W.S., Von Schacky C. (2004) RBC EPA+DHA: a new risk factor for sudden
cardiac death? Prev. Med. 39: 212-220.
� Heude B., Ducimetiere P., Berr C. (2003) Cognitive decline and fatty acid
composition of erythrocyte mebranes-The EVA study. Am. Clinic. Nutr. 77: 803– 8.
� Hibbeln J.R., Salem N. (1995) Dietary polyunsaturated fatty acids and depression:
when cholesterol does not satisfy. Am. J. Clin. Nutr. 62: 1-9.
� Hirayama S., Hamazaki T., Terasawa K. (2004) Effect of docosahexaenoic
acidcontaining food administration on symptoms of attention-deficit/hyperactivity
disorder:a placebo-controlled double-blind study. Eur. J. Clin. Nutr. 58: 467-473.
� Holness M.J., Greenwood G.K., Smith N.D., Sugden M.C. (2003) Diabetogenic
impact of long-chain omega-3 fatty acids on pancreatic beta-cell function and the
regulation of endogenous glucose production. Endocrinology 144: 3858– 68.
� Hornych A., Oravec S., Girault F., Forette B., Horrobin DF. (2002) The effect of
gammalinolenic acid on plasma and membrane lipids and renal prostaglandin
synthesis in older subjects. Bratisl. Lek. Listy 103 (3): 101-107.
� Horrobin D.F. (1993) Fatty acid metabolism in health and disease: the role of 6desaturase.
Am. J. Clin. Nutr. 57S: 732S-736S.
� Hubard V.S., Dunn G.D. (1980) Fatty acid composition of erythrocyte
phospholipids from patients with cystic fibrosis. Clin. Chim. Acta 102: 115-118.
40